Concepedia

Author

Leonie Voorwerk

The Netherlands Cancer InstituteORCID

Also Known As

Jose van den Berg, L Voorwerk, L. Voorwerk, Leonie Voorwerk, Voorwerk, Leonie

40

Publications

3.5K

Citations

18

H-Index

27

Concepts

All Affiliations

The Netherlands Cancer InstituteOncode InstitutePeter MacCallum Cancer CentreGZA Ziekenhuizen Campus Sint-AugustinusThe University of Texas MD Anderson Cancer Center
LV

About

Leonie Voorwerk is an author at The Netherlands Cancer Institute specializing in medicine, breast cancer, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

1.4K

2

Immunology

6

6

1.3K

3

Cell Biology

3

3

253

4

Health Sciences

1

1

23

5

Pathology

1

1

14

Leonie Voorwerk

×

17

Publications

2.8K

Citations

14

H-Index

YearCitations

High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types

Daniel J. McGrail, P.G. Pilié, N.U. Rashid,

Annals of Oncology

2021

1K

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

Leonie Voorwerk, Maarten Slagter, Hugo M. Horlings,

Nature Medicine

2019

854

Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer

Dora Hammerl, John W.M. Martens, Mieke Timmermans,

Nature Communications

2021

229

IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer

Olga Blomberg, Lorenzo Spagnuolo, Hannah Garner,

Cancer Cell

2022

192

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

Zuzana Kos, Elvire Roblin, Rim S. Kim,

npj Breast Cancer

2020

190

LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer

Iván Pérez-Núñez, Catalina Rozalén, José Ángel Palomeque,

Nature Cancer

2022

58

Immune landscape of breast tumors with low and intermediate estrogen receptor expression

Leonie Voorwerk, Joyce Sanders, Milou S. Keusters,

npj Breast Cancer

2023

57

Adaptive phase II randomized trial of nivolumab after induction treatment in triple negative breast cancer (TONIC trial): Final response data stage I and first translational data.

Marleen Kok, Leonie Voorwerk, Hugo M. Horlings,

Journal of Clinical Oncology

2018

40

PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial

Leonie Voorwerk, Olga I. Isaeva, Hugo M. Horlings,

Nature Cancer

2023

35

IGF‐1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER‐positive breast cancer

Dinja T. Kruger, Xanthippi Alexi, Mark Opdam,

International Journal of Cancer

2019

32

Page 1